相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The SIRPα-CD47 immune checkpoint in NK cells
Tobias Deuse et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding
Robyn J. Puro et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential
Linlin Ma et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a
Marisa O. Peluso et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
CD47 (Cluster of differentiation 47): an anti-phagocytic receptor with a multitude of signaling functions
Pascal Leclair et al.
ANIMAL CELLS AND SYSTEMS (2020)
Signaling Regulatory Protein (SIRP)α-CD47 Blockade Joins the Ranks of Immune Checkpoint Inhibition
Andre Veillette et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
Branimir Sikic et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression
Lara M. Myers et al.
NATURE COMMUNICATIONS (2019)
Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4
Yuan Xiao Zhu et al.
BLOOD CANCER JOURNAL (2019)
Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients
Jingping Yuan et al.
CANCER CELL INTERNATIONAL (2019)
Clodronate-Liposome Mediated Macrophage Depletion Abrogates Multiple Myeloma Tumor Establishment In Vivo
Khatora S. Opperman et al.
NEOPLASIA (2019)
The First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Azacitidine Is Effective in MDS and AML Patients: Ongoing Phase 1b Results
David A. Sallman et al.
BLOOD (2019)
Blocking don't eat me signal of CD47-SIRPα in hematological malignancies, an in-depth review
Atlantis Russ et al.
BLOOD REVIEWS (2018)
CD47-signal regulatory protein signaling system and its application to cancer immunotherapy
Yoji Murata et al.
CANCER SCIENCE (2018)
SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy
Andre Veillette et al.
TRENDS IN IMMUNOLOGY (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding
Penka S. Petrova et al.
CLINICAL CANCER RESEARCH (2017)
The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
Hanke L. Matlung et al.
IMMUNOLOGICAL REVIEWS (2017)
Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
Nan Guo Ring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non-Small Cell Lung Cancer
Xuyao Zhang et al.
CANCER IMMUNOLOGY RESEARCH (2017)
TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets
Gloria H. Y. Lin et al.
PLOS ONE (2017)
The humanized anti-CD47 monclonal antibody, CC-90002, has antitumor activity in vitro and in vivo
Rama Krishna Narla et al.
CANCER RESEARCH (2017)
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
Kipp Weiskopf et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
CD47 protein expression in acute myeloid leukemia: A tissue microarray-based analysis
Serena Galli et al.
LEUKEMIA RESEARCH (2015)
CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer
Kazumichi Yoshida et al.
CANCER MEDICINE (2015)
Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
Jie Liu et al.
PLOS ONE (2015)
The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment
Chika Iwamoto et al.
EXPERIMENTAL HEMATOLOGY (2014)
Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
Naofumi Mukaida et al.
MEDIATORS OF INFLAMMATION (2014)
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
Diane Tseng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Macrophages in Tumor Microenvironments and the Progression of Tumors
Ning-Bo Hao et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
A. Lopez-Girona et al.
LEUKEMIA (2012)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Fernando O. Martinez et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo
Aran F. Labrijn et al.
NATURE BIOTECHNOLOGY (2009)
Macrophages and cancer
Alessandra Nardin
Frontiers in Bioscience-Landmark (2008)
Species- and cell type-specific interactions between CD47 and human SIRPα
S Subramanian et al.
BLOOD (2006)
Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myeloma
Y Kikuchi et al.
LEUKEMIA RESEARCH (2005)
A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells
Y Kikuchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Post-transcriptional regulation of glucose transporter-1 by an AU-rich element in the 3′UTR and by hnRNP A2
ME Griffin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Role of CD47 as a marker of self on red blood cells
PA Oldenborg et al.
SCIENCE (2000)
分享论文
